Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Black cohosh: just another phytoestrogen?

Volker Viereck1, Günter Emons, Wolfgang Wuttke

  • 1Department of Obstetrics and Gynecology, Georg-August-University of Göttingen, Robert-Koch-Strasse 40, D-37075 Göttingen, Germany.

Trends in Endocrinology and Metabolism: TEM
|June 2, 2005
PubMed
Summary

Phytoestrogens offer minimal relief for menopausal symptoms, unlike black cohosh (Actaea racemosa) extracts, which show significant efficacy and safety for menopausal complaints and mood disturbances.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

One-year outcome after laser treatment of vulvar lichen sclerosus: a prospective observational trial.

Archives of gynecology and obstetrics·2026
Same author

Letter: Vaginal Lasers for Treating Stress Urinary Incontinence in Women: An Abridged Cochrane Systematic Review and Meta-Analysis.

The Journal of urology·2025
Same author

Vaginal Erbium Laser for the Treatment of Mild-to-Moderate Stress Urinary Incontinence: A Multicentre Randomised Sham-Controlled Trial.

BJOG : an international journal of obstetrics and gynaecology·2025
Same author

Female stress urinary incontinence: erbium-doped yttrium aluminum garnet laser.

American journal of obstetrics and gynecology·2025
Same author

A randomized controlled trial to evaluate a novel dual laser therapy for vulvar lichen sclerosus: exploratory study assessing the impact of menopausal status.

Menopause (New York, N.Y.)·2025
Same author

Endometrial Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry Number 032/034-OL, September 2022) - Part 2 with Recommendations on the Therapy of Precancerous Lesions and Early-stage Endometrial Cancer, Surgical Therapy, Radiotherapy and Drug-based Therapy, Follow-up Care, Recurrence and Metastases, Psycho-oncological Care, Palliative Care, Patient Education, and Rehabilitative and Physiotherapeutic Care.

Geburtshilfe und Frauenheilkunde·2024

Area of Science:

  • Phytomedicine
  • Menopause research
  • Endocrinology

Background:

  • Phytoestrogens, like soy isoflavones, have shown limited efficacy for menopausal symptoms.
  • Isoflavones may interact with estrogen receptors and interfere with cancer therapies.
  • Actaea racemosa (black cohosh) is a botanical remedy with potential benefits for menopausal transition.

Purpose of the Study:

  • To evaluate the effectiveness of phytoestrogens and Actaea racemosa for managing menopausal symptoms.
  • To assess the safety profile of Actaea racemosa extracts.
  • To explore the impact of these natural compounds on sleep, mood, and bone health during menopause.

Main Methods:

  • Review of clinical trials on phytoestrogens (e.g., soy-rich diets) and Actaea racemosa extracts.

Related Experiment Videos

  • Analysis of studies investigating effects on classic menopausal symptoms, sleep disturbances, mood swings, and osteoprotective properties.
  • Examination of safety data, including high-dose administration of Actaea racemosa.

    • Main Results:

    • Phytoestrogens demonstrated minimal positive effects on menopausal symptoms, with soy diets showing slight benefits for sleep and mood.
    • Diet duration prior to menopause onset influenced phytoestrogen efficacy.
    • Actaea racemosa extracts exhibited significant efficacy in alleviating menopausal complaints, including psychic issues.
    • Osteoprotective properties were noted for Actaea racemosa, with a favorable safety profile even at increased dosages.

    Conclusions:

    • Actaea racemosa extracts are a promising, safe option for managing menopausal symptoms, offering superior relief compared to phytoestrogens.
    • Further research may elucidate the mechanisms behind Actaea racemosa's benefits for menopausal women.
    • Individual responses to phytoestrogens vary, and their use requires consideration of potential interactions with other therapies.